617 related articles for article (PubMed ID: 22008728)
1. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28.
Owen DR; Yeo AJ; Gunn RN; Song K; Wadsworth G; Lewis A; Rhodes C; Pulford DJ; Bennacef I; Parker CA; StJean PL; Cardon LR; Mooser VE; Matthews PM; Rabiner EA; Rubio JP
J Cereb Blood Flow Metab; 2012 Jan; 32(1):1-5. PubMed ID: 22008728
[TBL] [Abstract][Full Text] [Related]
2. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation.
Kreisl WC; Jenko KJ; Hines CS; Lyoo CH; Corona W; Morse CL; Zoghbi SS; Hyde T; Kleinman JE; Pike VW; McMahon FJ; Innis RB;
J Cereb Blood Flow Metab; 2013 Jan; 33(1):53-8. PubMed ID: 22968319
[TBL] [Abstract][Full Text] [Related]
3. Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
Owen DR; Gunn RN; Rabiner EA; Bennacef I; Fujita M; Kreisl WC; Innis RB; Pike VW; Reynolds R; Matthews PM; Parker CA
J Nucl Med; 2011 Jan; 52(1):24-32. PubMed ID: 21149489
[TBL] [Abstract][Full Text] [Related]
4. Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.
Mizrahi R; Rusjan PM; Kennedy J; Pollock B; Mulsant B; Suridjan I; De Luca V; Wilson AA; Houle S
J Cereb Blood Flow Metab; 2012 Jun; 32(6):968-72. PubMed ID: 22472607
[TBL] [Abstract][Full Text] [Related]
5. Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28.
Narendran R; Lopresti BJ; Mason NS; Deuitch L; Paris J; Himes ML; Kodavali CV; Nimgaonkar VL
J Neurosci; 2014 Jul; 34(30):9945-50. PubMed ID: 25057196
[TBL] [Abstract][Full Text] [Related]
6. Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.
Owen DR; Howell OW; Tang SP; Wells LA; Bennacef I; Bergstrom M; Gunn RN; Rabiner EA; Wilkins MR; Reynolds R; Matthews PM; Parker CA
J Cereb Blood Flow Metab; 2010 Sep; 30(9):1608-18. PubMed ID: 20424634
[TBL] [Abstract][Full Text] [Related]
7. Influence of alcoholism and cholesterol on TSPO binding in brain: PET [
Kim SW; Wiers CE; Tyler R; Shokri-Kojori E; Jang YJ; Zehra A; Freeman C; Ramirez V; Lindgren E; Miller G; Cabrera EA; Stodden T; Guo M; Demiral ŞB; Diazgranados N; Park L; Liow JS; Pike V; Morse C; Vendruscolo LF; Innis RB; Koob GF; Tomasi D; Wang GJ; Volkow ND
Neuropsychopharmacology; 2018 Aug; 43(9):1832-1839. PubMed ID: 29777199
[TBL] [Abstract][Full Text] [Related]
8. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker.
Kreisl WC; Fujita M; Fujimura Y; Kimura N; Jenko KJ; Kannan P; Hong J; Morse CL; Zoghbi SS; Gladding RL; Jacobson S; Oh U; Pike VW; Innis RB
Neuroimage; 2010 Feb; 49(4):2924-32. PubMed ID: 19948230
[TBL] [Abstract][Full Text] [Related]
9. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
[TBL] [Abstract][Full Text] [Related]
10. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
[TBL] [Abstract][Full Text] [Related]
11. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.
Zanotti-Fregonara P; Zhang Y; Jenko KJ; Gladding RL; Zoghbi SS; Fujita M; Sbardella G; Castellano S; Taliani S; Martini C; Innis RB; Da Settimo F; Pike VW
ACS Chem Neurosci; 2014 Oct; 5(10):963-71. PubMed ID: 25123416
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
[TBL] [Abstract][Full Text] [Related]
14. (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease.
Kreisl WC; Lyoo CH; Liow JS; Wei M; Snow J; Page E; Jenko KJ; Morse CL; Zoghbi SS; Pike VW; Turner RS; Innis RB
Neurobiol Aging; 2016 Aug; 44():53-61. PubMed ID: 27318133
[TBL] [Abstract][Full Text] [Related]
15. Influence of TSPO genotype on 11C-PBR28 standardized uptake values.
Yoder KK; Nho K; Risacher SL; Kim S; Shen L; Saykin AJ
J Nucl Med; 2013 Aug; 54(8):1320-2. PubMed ID: 23785173
[TBL] [Abstract][Full Text] [Related]
16. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients.
Harberts E; Datta D; Chen S; Wohler JE; Oh U; Jacobson S
J Neuroimmune Pharmacol; 2013 Mar; 8(1):51-7. PubMed ID: 22956240
[TBL] [Abstract][Full Text] [Related]
17.
Kobayashi M; Jiang T; Telu S; Zoghbi SS; Gunn RN; Rabiner EA; Owen DR; Guo Q; Pike VW; Innis RB; Fujita M
J Cereb Blood Flow Metab; 2018 Mar; 38(3):393-403. PubMed ID: 28322082
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of [
Varnäs K; Cselényi Z; Jucaite A; Halldin C; Svenningsson P; Farde L; Varrone A
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):367-375. PubMed ID: 30270409
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of (S)-[
Ramakrishnan NK; Hird M; Thompson S; Williamson DJ; Qiao L; Owen DR; Brooks AF; Scott PJH; Bacallado S; O'Brien JT; Aigbirhio FI
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):125-136. PubMed ID: 34405276
[TBL] [Abstract][Full Text] [Related]
20. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [
Collste K; Plavén-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; ; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Mol Psychiatry; 2017 Jun; 22(6):850-856. PubMed ID: 28194003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
